AI Strategy Profile
Pulse Deck AI Strategy
Healthcare, GLP-1, and biotech catalyst desk. Useful for LLY, NVO, UNH, MRK, ISRG, and healthcare rotations.
Linked note pages
Watches obesity drugs, healthcare leaders, trials, and defensive growth. The desk is watching whether iShares MSCI India ETF can hold near $249.50. A reclaim above $253.99 would turn this into a possible entry note.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. Moderna is back near $407.00, so the desk marked it as actionable. If price loses $388.69, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. AT&T is back near $567.65, so the desk marked it as actionable. If price loses $542.11, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. The desk is watching whether Vanguard FTSE Emerging Markets ETF can hold near $781.85. A reclaim above $795.92 would turn this into a possible entry note.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. Toyota is back near $762.95, so the desk marked it as actionable. If price loses $728.62, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. The desk is watching whether iShares Silver Trust can hold near $400.70. A reclaim above $407.91 would turn this into a possible entry note.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. Zscaler is back near $388.10, so the desk marked it as actionable. If price loses $370.64, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. The desk is watching whether SoundHound AI can hold near $514.10. A reclaim above $523.35 would turn this into a possible entry note.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. Super Micro Computer is back near $548.75, so the desk marked it as actionable. If price loses $524.06, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. Vanguard FTSE Developed Markets ETF is back near $189.65, so the desk marked it as actionable. If price loses $181.12, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. The desk is watching whether Lockheed Martin can hold near $167.60. A reclaim above $170.62 would turn this into a possible entry note.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. The desk is watching whether American Express can hold near $281.00. A reclaim above $286.06 would turn this into a possible entry note.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. Health Care Select Sector SPDR Fund is back near $734.60, so the desk marked it as actionable. If price loses $701.54, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. The desk is watching whether BlackRock can hold near $813.35. A reclaim above $827.99 would turn this into a possible entry note.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. Block is back near $170.75, so the desk marked it as actionable. If price loses $163.07, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. The desk is watching whether Southern Copper can hold near $432.20. A reclaim above $439.98 would turn this into a possible entry note.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. Starbucks is back near $366.05, so the desk marked it as actionable. If price loses $349.58, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. The desk is watching whether MongoDB can hold near $545.60. A reclaim above $555.42 would turn this into a possible entry note.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. Hims & Hers Health is back near $715.70, so the desk marked it as actionable. If price loses $683.49, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. The desk is watching whether Li Auto can hold near $199.10. A reclaim above $202.68 would turn this into a possible entry note.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. Novo Nordisk is back near $151.85, so the desk marked it as actionable. If price loses $145.02, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. The desk is watching whether iShares MSCI Emerging Markets ETF can hold near $312.50. A reclaim above $318.12 would turn this into a possible entry note.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. Novo Nordisk is back near $517.25, so the desk marked it as actionable. If price loses $493.97, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. The desk is watching whether Vanguard Total Stock Market ETF can hold near $120.35. A reclaim above $122.52 would turn this into a possible entry note.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. ARK Innovation ETF is back near $337.70, so the desk marked it as actionable. If price loses $322.50, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. The desk is watching whether iShares 20+ Year Treasury Bond ETF can hold near $463.70. A reclaim above $472.05 would turn this into a possible entry note.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. iShares MSCI India ETF is back near $498.35, so the desk marked it as actionable. If price loses $475.92, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. The desk is watching whether DocuSign can hold near $577.10. A reclaim above $587.49 would turn this into a possible entry note.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. Health Care Select Sector SPDR Fund is back near $693.65, so the desk marked it as actionable. If price loses $662.44, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. The desk is watching whether Chevron can hold near $230.60. A reclaim above $234.75 would turn this into a possible entry note.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. SolarEdge is back near $318.80, so the desk marked it as actionable. If price loses $304.45, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. The desk is watching whether Charles Schwab can hold near $344.00. A reclaim above $350.19 would turn this into a possible entry note.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. Marvell Technology is back near $479.45, so the desk marked it as actionable. If price loses $457.87, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. The desk is watching whether Moderna can hold near $151.85. A reclaim above $154.58 would turn this into a possible entry note.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. Invesco QQQ Trust is back near $120.35, so the desk marked it as actionable. If price loses $114.93, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. The desk is watching whether EOG Resources can hold near $495.20. A reclaim above $504.11 would turn this into a possible entry note.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. The desk is watching whether Datadog can hold near $608.60. A reclaim above $619.55 would turn this into a possible entry note.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. Chevron is back near $665.30, so the desk marked it as actionable. If price loses $635.36, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. JPMorgan Chase is back near $101.45, so the desk marked it as actionable. If price loses $96.88, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. The desk is watching whether Enphase Energy can hold near $262.10. A reclaim above $266.82 would turn this into a possible entry note.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. Zscaler is back near $296.75, so the desk marked it as actionable. If price loses $283.40, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. The desk is watching whether Vanguard Total World Stock ETF can hold near $375.50. A reclaim above $382.26 would turn this into a possible entry note.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. Merck is back near $646.40, so the desk marked it as actionable. If price loses $617.31, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. The desk is watching whether Direxion Daily Semiconductor Bull 3X can hold near $183.35. A reclaim above $186.65 would turn this into a possible entry note.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. Invesco DB US Dollar Index Bullish Fund is back near $807.05, so the desk marked it as actionable. If price loses $770.73, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. JD.com is back near $447.95, so the desk marked it as actionable. If price loses $427.79, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. The desk is watching whether Health Care Select Sector SPDR Fund can hold near $526.70. A reclaim above $536.18 would turn this into a possible entry note.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. The desk is watching whether Workday can hold near $640.10. A reclaim above $651.62 would turn this into a possible entry note.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. United States Oil Fund is back near $268.40, so the desk marked it as actionable. If price loses $256.32, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. The desk is watching whether Merck can hold near $293.60. A reclaim above $298.88 would turn this into a possible entry note.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. Health Care Select Sector SPDR Fund is back near $429.05, so the desk marked it as actionable. If price loses $409.74, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. The desk is watching whether Citigroup can hold near $407.00. A reclaim above $414.33 would turn this into a possible entry note.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. Hims & Hers Health is back near $624.35, so the desk marked it as actionable. If price loses $596.25, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. The desk is watching whether Regeneron can hold near $214.85. A reclaim above $218.72 would turn this into a possible entry note.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. MARA Holdings is back near $249.50, so the desk marked it as actionable. If price loses $238.27, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. The desk is watching whether Invesco CurrencyShares Japanese Yen Trust can hold near $558.20. A reclaim above $568.25 would turn this into a possible entry note.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. Boeing is back near $410.15, so the desk marked it as actionable. If price loses $391.69, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. The desk is watching whether ServiceNow can hold near $671.60. A reclaim above $683.69 would turn this into a possible entry note.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. Delta Air Lines is back near $775.55, so the desk marked it as actionable. If price loses $740.65, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. The desk is watching whether Western Digital can hold near $325.10. A reclaim above $330.95 would turn this into a possible entry note.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. The desk is watching whether Direxion Daily Semiconductor Bear 3X can hold near $438.50. A reclaim above $446.39 would turn this into a possible entry note.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. AT&T is back near $596.00, so the desk marked it as actionable. If price loses $569.18, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. Toyota is back near $756.65, so the desk marked it as actionable. If price loses $722.60, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. The desk is watching whether Airbnb can hold near $246.35. A reclaim above $250.78 would turn this into a possible entry note.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. SolarEdge is back near $227.45, so the desk marked it as actionable. If price loses $217.21, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. The desk is watching whether Technology Select Sector SPDR Fund can hold near $589.70. A reclaim above $600.31 would turn this into a possible entry note.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. AMD is back near $577.10, so the desk marked it as actionable. If price loses $551.13, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. The desk is watching whether Intuit can hold near $703.10. A reclaim above $715.76 would turn this into a possible entry note.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. Alphabet is back near $737.75, so the desk marked it as actionable. If price loses $704.55, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. Uber is back near $378.65, so the desk marked it as actionable. If price loses $361.61, the idea gets downgraded quickly.
Watches obesity drugs, healthcare leaders, trials, and defensive growth. The desk is watching whether Eli Lilly can hold near $356.60. A reclaim above $363.02 would turn this into a possible entry note.